Biologic Impact of Proteasome Inhibition in Multiple Myeloma Cells—From the Aspects of Preclinical Studies

Seminars in Hematology - United Kingdom
doi 10.1053/j.seminhematol.2012.04.006
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Elsevier BV

Related search

Thiasyrbactins Induce Cell Death via Proteasome Inhibition in Multiple Myeloma Cells

Anticancer Research
MedicineCancer ResearchOncology
2018English

Preclinical Animal Models of Multiple Myeloma

BoneKEy Reports
2016English

Preclinical Evaluation of Invariant Natural Killer T-Cells in the 5T33 Multiple Myeloma Model

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Novel Strategies in the Treatment of Multiple Myeloma: From Proteasome Inhibitors to Immunotherapy

Journal of Cell Science & Therapy
2010English

Biologic Frontiers in Multiple Myeloma: From Biomarker Identification to Clinical Practice

Clinical Cancer Research
Cancer ResearchOncology
2013English

Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma

Pharmaceuticals
Molecular MedicinePharmaceutical Science
2014English

Investigating Effects of Proteasome Inhibitor on Multiple Myeloma Cells Using Confocal Raman Microscopy

Sensors
InstrumentationInformation SystemsElectronic EngineeringBiochemistryAnalytical ChemistryMolecular Physics,ElectricalAtomicMedicineOptics
2016English

Sensitizing Human Multiple Myeloma Cells to the Proteasome Inhibitor Bortezomib by Novel Curcumin Analogs

International Journal of Molecular Medicine
MedicineGenetics
2011English

Nelfinavir Augments Proteasome Inhibition by Bortezomib in Myeloma Cells and Overcomes Bortezomib and Carfilzomib Resistance

Blood Cancer Journal
OncologyHematology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy